Team

Jia develops targeted lipid nanoparticle platforms for precision geneand drug delivery at the University of Pennsylvania. Her work focuseson engineering cell-specific delivery and immunomodulation strategiesto treat CNS and cardiovascular diseases, including stroke, multiplesclerosis, and atherosclerosis. She is actively advancing thesetechnologies toward clinical translation and commercialization as aco-founder of NanoMuse, LLC.